FDA approves lower-cost daily weight loss pill from Eli Lilly
Berkeley Lovelace Jr.NBC News
A new daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the FDA approval of Novo Nordisk’s Wegovy pill.
The FDA approval comes as the GLP-1 market continues to expand, with newer options offering more weight loss, different forms or lower prices.
Reported by NBC NewsRead original
Coverage from 1 source
Coverage by lean
- Unknown1
Comments
Loading comments…
Sign in to join the discussion.
Sign in with SpryLogin